Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development.

van Veelen W, Klompmaker R, Gloerich M, van Gasteren CJ, Kalkhoven E, Berger R, Lips CJ, Medema RH, Höppener JW, Acton DS.

Int J Cancer. 2009 Jan 15;124(2):339-45. doi: 10.1002/ijc.23977.

PMID:
18942719
[PubMed - indexed for MEDLINE]
2.

Management of medullary thyroid carcinoma.

Jiménez C, Hu MI, Gagel RF.

Endocrinol Metab Clin North Am. 2008 Jun;37(2):481-96, x-xi. doi: 10.1016/j.ecl.2008.03.001. Review.

PMID:
18502338
[PubMed - indexed for MEDLINE]
3.

[Medullary thyroid carcinoma and some of its particularities].

Sidibé el H.

Sante. 2007 Jan-Mar;17(1):51-5. Review. French.

PMID:
17897902
[PubMed - indexed for MEDLINE]
4.

Genetic mutations in thyroid carcinoma.

Taccaliti A, Boscaro M.

Minerva Endocrinol. 2009 Mar;34(1):11-28. Review.

PMID:
19209125
[PubMed - indexed for MEDLINE]
5.

New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.

Jaggard MK, MacRae C, Ifeacho S, Robinson S, Tolley NS.

J Laryngol Otol. 2009 Jul;123(7):796-800. doi: 10.1017/S0022215108003472. Epub 2008 Sep 4. Review.

PMID:
18771606
[PubMed - indexed for MEDLINE]
6.

Expression of the calcitonin gene family in medullary thyroid carcinoma.

Schifter S.

Peptides. 1997;18(2):307-17. Review.

PMID:
9149305
[PubMed - indexed for MEDLINE]
7.

Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.

Cerrato A, De Falco V, Santoro M.

J Mol Endocrinol. 2009 Oct;43(4):143-55. doi: 10.1677/JME-09-0024. Epub 2009 Apr 21. Review.

PMID:
19383830
[PubMed - indexed for MEDLINE]
Free Article
8.

Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma.

Santarpia L, Ye L, Gagel RF.

J Intern Med. 2009 Jul;266(1):99-113. doi: 10.1111/j.1365-2796.2009.02112.x. Review.

PMID:
19522829
[PubMed - indexed for MEDLINE]
9.

Thyroid cancer genetics: multiple endocrine neoplasia type 2, non-medullary familial thyroid cancer, and familial syndromes associated with thyroid cancer.

Richards ML.

Surg Oncol Clin N Am. 2009 Jan;18(1):39-52, viii. doi: 10.1016/j.soc.2008.08.002. Review.

PMID:
19056041
[PubMed - indexed for MEDLINE]
10.

[Hereditary thyroid cancer].

Dralle H, Machens A, Lorenz K.

Chirurg. 2008 Nov;79(11):1017-28. doi: 10.1007/s00104-008-1558-y. Review. German.

PMID:
18818894
[PubMed - indexed for MEDLINE]
11.

Molecular biology of thyroid neoplasms.

Satta MA, Nanni S, Della Casa S, Pontecorvi A.

Rays. 2000 Apr-Jun;25(2):151-61. Review. English, Italian.

PMID:
11370534
[PubMed - indexed for MEDLINE]
12.

Multiple endocrine neoplasms.

Falchetti A, Marini F, Luzi E, Tonelli F, Brandi ML.

Best Pract Res Clin Rheumatol. 2008 Mar;22(1):149-63. doi: 10.1016/j.berh.2007.11.010. Review. Erratum in: Best Pract Res Clin Rheumatol. 2008 Dec;22(6):III. Brandt, Maria Luisa [corrected to Brandi, Maria Luisa].

PMID:
18328987
[PubMed - indexed for MEDLINE]
13.

Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities.

Machens A, Lorenz K, Dralle H.

J Intern Med. 2009 Jul;266(1):114-25. doi: 10.1111/j.1365-2796.2009.02113.x. Review.

PMID:
19522830
[PubMed - indexed for MEDLINE]
14.

Epigenetic dysregulation in thyroid neoplasia.

Kondo T, Asa SL, Ezzat S.

Endocrinol Metab Clin North Am. 2008 Jun;37(2):389-400, ix. doi: 10.1016/j.ecl.2007.12.002. Review.

PMID:
18502333
[PubMed - indexed for MEDLINE]
15.

New therapeutic approaches to treat medullary thyroid carcinoma.

Schlumberger M, Carlomagno F, Baudin E, Bidart JM, Santoro M.

Nat Clin Pract Endocrinol Metab. 2008 Jan;4(1):22-32. Review.

PMID:
18084343
[PubMed - indexed for MEDLINE]
16.

Dysregulated RET signaling in thyroid cancer.

Castellone MD, Santoro M.

Endocrinol Metab Clin North Am. 2008 Jun;37(2):363-74, viii. doi: 10.1016/j.ecl.2008.02.006. Review.

PMID:
18502331
[PubMed - indexed for MEDLINE]
17.

The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy.

Sakorafas GH, Friess H, Peros G.

Endocr Relat Cancer. 2008 Dec;15(4):871-84. doi: 10.1677/ERC-08-0098. Review.

PMID:
19015274
[PubMed - indexed for MEDLINE]
Free Article
18.

Medullary thyroid carcinoma and biomarkers: past, present and future.

van Veelen W, de Groot JW, Acton DS, Hofstra RM, Höppener JW, Links TP, Lips CJ.

J Intern Med. 2009 Jul;266(1):126-40. doi: 10.1111/j.1365-2796.2009.02106.x. Review.

PMID:
19522831
[PubMed - indexed for MEDLINE]
19.

The p16INK4a/CDKN2A tumor suppressor and its relatives.

Ruas M, Peters G.

Biochim Biophys Acta. 1998 Oct 14;1378(2):F115-77. Review. No abstract available.

PMID:
9823374
[PubMed - indexed for MEDLINE]
Free Article
20.

MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?

Castellani MR, Seregni E, Maccauro M, Chiesa C, Aliberti G, Orunesu E, Bombardieri E.

Q J Nucl Med Mol Imaging. 2008 Dec;52(4):430-40. Review.

PMID:
19088696
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk